インドメタシン持続性製剤の溶出試験
スポンサーリンク
概要
- 論文の詳細を見る
The dissolution pattern of 5 kinds of commercial indomethacin capsules were measured with the U.S.P. dissolution tester in pH shift test solution adding 0.25% Tween 80 in consideration of the acidity in the gastrointestinal tract. Sample A was not coated capsules containing 25mg of indomethacin, whereas samples B and C were prolonged activity capsules containing 25mg, and samples D and E were prolonged activity capsules containing 37.5mg. pH of the medium was designed to rise gradually from 2.3 to 3.7 in the first 150 min, rapidly from 3.7 to 6.2 in the subsequent 30 min, and gradually up to 6.9 after 300 min. The following results were obtained : 1) Sample A : The time required for 100% dissolution was about 30 min. 2) Samples B and C : The dissolution pattern of B was apparently different from that of sample C. About 100% of sample B was dissolved after 300 min, compared with about 75% of sample C. 3) Samples D and E : The dissolution pattern of sample D was apparently different from that of sample C. About 100% of sample D was dissolved after 300 min, as against about 80% of sample E.
- 日本医療薬学会の論文
- 1982-12-20
著者
関連論文
- 1-(2-Tetrahydrofuryl)-5-Fluorouracilを主薬とする制癌剤について
- 消化酵素剤のリパーゼ活性におよぼす胆汁酸の影響
- L-ケフレックスの有効血中濃度持続化におよぼす食餌因子の影響
- 高速液体クロマトグラフによるFAD注射剤の比較検討
- 病院におけるグルタールアルデヒドによる消毒法の実際
- L-ケフレックス顆粒の耐酸性と溶出性の評価
- β-ガラクトシダーゼ製剤の安定性
- フトラフール腸溶性顆粒の腸溶性皮膜の耐酸性および溶出性に関する評価
- リハビリテーションにおけるクロルヘキシジン浴について
- インドメタシン持続性製剤の溶出試験
- フトラフール腸溶性製剤の耐酸性および溶出性の評価
- γ-オリザノール (γ-OZ) を主薬とする細粒剤
- 1-(2-Tetrahydrofuryl)-5-Fluorouracil細粒剤の物性試験、溶出試験